KERREY J ROBERT 4

What Happened

• Robert J. Kerrey, a director of Tenet Healthcare Corp. (THC), was granted 1,464 restricted stock units (RSUs) on 2026-05-27. The Form 4 lists these as a derivative award (code A) at $0.00 (grant value reported as $0 on the Form 4). These RSUs are the economic equivalent of one share each and will convert to shares (or cash as elected) on vesting.

Key Details

• Transaction date: 2026-05-27; Form 4 filed: 2026-05-28 (filed the next day, within typical Form 4 timing).
• Transaction type/code: Award/Grant (A); 1,464 RSUs @ $0.00 (derivative grant).
• Shares owned after the transaction: not specified in the provided filing.
• Footnote: RSUs vest on the first anniversary of the grant. The reporting person may elect to receive up to 37% of the RSUs in cash in lieu of shares.
• Filing timeliness: filed one day after the grant (generally timely for Form 4 reporting).

Context

• This was a compensation grant, not an open-market purchase or sale. RSU awards are routine director compensation and do not represent an immediate buy or sell decision. Each RSU converts to one share (or cash per the election) upon vesting, so the economic impact depends on Tenet’s share price at that future date.